Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.36 +0.14 (+1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Selling, General & Administrative (2015 - 2026)

Updated

Cartesian Therapeutics (RNAC) recorded Selling, General & Administrative of $8.72 million in Q2 2026, up 20.5% from $7.24 million a year earlier and up 22.6% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Selling, General & Administrative (2015 - 2026) Analysis & Trends

On a TTM basis, Cartesian Therapeutics' Selling, General & Administrative came in at $31.75 million as of Jun 30, 2026, up 8.7% year-over-year; for FY2025, it was $31.47 million, up 4.5% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $30.13 million in FY2024 (-25.5%), $40.45 million in FY2023 (+69.5%), $23.86 million in FY2022 (+14.0%) and $20.94 million in FY2021 (+10.7%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q1 2024.
  • On a year-over-year basis, Selling, General & Administrative rose in four of the last eight quarters, with an average decline of 4.8%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 248.5% in Q4 2023, against a decline of 67.8% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.11 million (Q1 2026), $8.2 million (Q4 2025) and $7.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Cartesian Therapeutics 216.87 Mn 216.87 Mn - 8.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.72 Mn
Mar 31, 2026 7.11 Mn
Dec 31, 2025 8.20 Mn
Sep 30, 2025 7.72 Mn
Jun 30, 2025 7.24 Mn
Mar 31, 2025 8.32 Mn
Dec 31, 2024 7.09 Mn
Sep 30, 2024 6.56 Mn
Jun 30, 2024 7.03 Mn
Mar 31, 2024 9.45 Mn
Dec 31, 2023 22.04 Mn
Sep 30, 2023 6.61 Mn
Jun 30, 2023 6.11 Mn
Mar 31, 2023 5.70 Mn
Dec 31, 2022 6.32 Mn
Sep 30, 2022 5.77 Mn
Jun 30, 2022 6.23 Mn
Mar 31, 2022 5.54 Mn
Dec 31, 2021 5.54 Mn
Sep 30, 2021 5.45 Mn
API Access

Cartesian Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RNAC&period=max&api_key=YOUR_API_KEY